GlassScriptPhysician profile
Mason Thornton
NPI 1497383764
$1,925.90
in general payments reported to CMS, 2019-2025
21 companies · $1,018 in 2025
The $1,018 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $14.00 · 2024: $894 · 2025: $1,018.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,905 · Education: $6.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,905.13 |
| Education | $6.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $354.31 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $352.50 | 2025 | Dupixent, Libtayo |
| Ucb, INC. | $266.78 | 2024 | Bimzelx |
| Genzyme Corporation | $173.23 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $139.59 | 2022-2024 | |
| Pfizer INC. | $129.31 | 2024-2025 | |
| Janssen Biotech, INC. | $123.00 | 2024-2025 | Tremfya, Stelara, Simponi Aria |
| Organon LLC | $70.90 | 2025 | Vtama |
| Arcutis Biotherapeutics, INC. | $48.16 | 2024-2025 | Zoryve |
| Incyte Corporation | $44.59 | 2024-2025 | Opzelura |
| E.R. Squibb & Sons, L.L.C. | $35.10 | 2024 | Sotyktu |
| Amgen INC. | $33.61 | 2025 | Otezla |
| Novartis Pharmaceuticals Corporation | $24.89 | 2025 | |
| Dermavant Sciences, INC. | $19.63 | 2024 | Vtama |
| Ani Pharmaceuticals, INC. | $18.02 | 2025 | Veregen |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $17.30 | 2025 | |
| Lilly USA, LLC | $16.99 | 2024 | Taltz, Olumiant |
| Botanix Sb INC | $16.03 | 2025 | Sofdra |
| Galderma Laboratories, L.P. | $14.30 | 2025 | Nemluvio |
| Strata Skin Sciences, INC. | $14.14 | 2025 | Xtrac |
| Leo Pharma INC. | $13.52 | 2025 | Spevigo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mason Thornton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.